UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Efficient synthetic methodology for the construction of dihydronaphthalene and benzosuberene molecular frameworks

Tetrahedron letters, 2019-01, Vol.60 (5), p.397-401

2019

Volltextzugriff (PDF)

Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3′-hydroxy-4′-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006)

Bioorganic & medicinal chemistry, 2013-11, Vol.21 (21), p.6831-6843

2013

Volltextzugriff (PDF)

Improved Methodology for the Synthesis of a Cathepsin B Cleavable Dipeptide Linker, Widely Used in Antibody-Drug Conjugate Research

Tetrahedron letters, 2018-10, Vol.59 (40), p.3594-3599

2018

Volltextzugriff (PDF)

Synthesis of the Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor, 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977, Belzutifan); Efficient Replication of Established Approaches

Tetrahedron letters, 2023-09, Vol.128, p.154691, Article 154691

2023

Volltextzugriff (PDF)

Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors

Molecules (Basel, Switzerland), 2021-04, Vol.26 (9), p.2551

2021

Volltextzugriff (PDF)

Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues

Bioorganic & medicinal chemistry, 2023-09, Vol.92, p.117400-117400, Article 117400

2023

Volltextzugriff (PDF)

Synthesis and biological evaluation of structurally diverse 6-aryl-3-Aroyl-Indole analogues as inhibitors of tubulin polymerization

European journal of medicinal chemistry, 2024-01, Vol.263, p.115794-115794, Article 115794

2024

Volltextzugriff (PDF)

Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization

Journal of medicinal chemistry, 2019-06, Vol.62 (11), p.5594-5615

2019

Volltextzugriff (PDF)

Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents

Bioorganic & medicinal chemistry, 2016-03, Vol.24 (5), p.938-956

2016

Volltextzugriff (PDF)

A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment

Integrative biology (Cambridge), 2011-04, Vol.3 (4), p.375-387

2011

Volltextzugriff (PDF)

Bioreductively Activatable Prodrug Conjugates of Combretastatin A‑1 and Combretastatin A‑4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia

Journal of natural products (Washington, D.C.), 2020-04, Vol.83 (4), p.937-954

2020

Volltextzugriff (PDF)

Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents

Bioorganic & medicinal chemistry, 2013-12, Vol.21 (24), p.8019-8032

2013

Volltextzugriff (PDF)

Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment

Cancers, 2022-08, Vol.14 (17), p.4208

2022

Volltextzugriff (PDF)

Mechanistic considerations in the synthesis of 2-aryl-indole analogues under Bischler–Mohlau conditions

Tetrahedron letters, 2015-06, Vol.56 (23), p.3624-3629

2015

Volltextzugriff (PDF)

Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment

Cancers, 2021-09, Vol.13 (19), p.4769

2021

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy

Bioorganic & medicinal chemistry, 2008-09, Vol.16 (17), p.8161-8171

2008

Volltextzugriff (PDF)

Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia

Bioorganic & medicinal chemistry letters, 2017-02, Vol.27 (3), p.636-641

2017

Volltextzugriff (PDF)

The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts

Cancer letters, 2015-12, Vol.369 (1), p.229-241

2015

Volltextzugriff (PDF)

Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L

Bioorganic & medicinal chemistry letters, 2017-03, Vol.27 (5), p.1304-1310

2017

Volltextzugriff (PDF)

Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues

MedChemComm, 2019-08, Vol.1 (8), p.1445-1456

2019

Volltextzugriff (PDF)

Synthesis of a 2‑Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A‑4 with Application as a Vascular Disrupting Agent

Journal of natural products (Washington, D.C.), 2013-09, Vol.76 (9), p.1668-1678

2013

Volltextzugriff (PDF)

Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization

Bioorganic & medicinal chemistry, 2015-12, Vol.23 (24), p.7497-7520

2015

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization

MedChemComm, 2016-12, Vol.7 (12), p.2418-2427

2016

Volltextzugriff (PDF)

Oxygen‐Sensing Chemiluminescent Iridium(III) 1,2‐Dioxetanes: Unusual Coordination and Activity

Analysis & sensing, 2023-01, Vol.3 (1), p.n/a

2023

Volltextzugriff (PDF)

Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents

MedChemComm, 2018-10, Vol.9 (10), p.1649-1662

2018

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(119)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Efficient synthetic methodology for the construction of dihydronaphthalene and benzosuberene molecular frameworks

Synthesis and biological evaluation of indole-based, anti-cancer agents inspired by the vascular disrupting agent 2-(3′-hydroxy-4′-methoxyphenyl)-3-(3″,4″,5″-trimethoxybenzoyl)-6-methoxyindole (OXi8006)

Improved Methodology for the Synthesis of a Cathepsin B Cleavable Dipeptide Linker, Widely Used in Antibody-Drug Conjugate Research

Synthesis of the Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor, 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977, Belzutifan); Efficient Replication of Established Approaches

Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors

Structure Guided Design, Synthesis, and Biological Evaluation of Oxetane-Containing Indole Analogues

Synthesis and biological evaluation of structurally diverse 6-aryl-3-Aroyl-Indole analogues as inhibitors of tubulin polymerization

Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization

Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents

A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment

Bioreductively Activatable Prodrug Conjugates of Combretastatin A‑1 and Combretastatin A‑4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia

Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents

Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment

Mechanistic considerations in the synthesis of 2-aryl-indole analogues under Bischler–Mohlau conditions

Imaging-Guided Evaluation of the Novel Small-Molecule Benzosuberene Tubulin-Binding Agent KGP265 as a Potential Therapeutic Agent for Cancer Treatment

Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy

Bioreductively activatable prodrug conjugates of phenstatin designed to target tumor hypoxia

The vascular disrupting activity of OXi8006 in endothelial cells and its phosphate prodrug OXi8007 in breast tumor xenografts

Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L

Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues

Synthesis of a 2‑Aryl-3-aroyl Indole Salt (OXi8007) Resembling Combretastatin A‑4 with Application as a Vascular Disrupting Agent

Structural interrogation of benzosuberene-based inhibitors of tubulin polymerization

Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization

Oxygen‐Sensing Chemiluminescent Iridium(III) 1,2‐Dioxetanes: Unusual Coordination and Activity

Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents

Suchergebnisse filtern